Intervention Protocol

Ivermectin versus benzimidazoles for treating strongyloides infection

  1. Cesar AJ Henriquez-Camacho1,*,
  2. Eduardo Gotuzzo1,2,
  3. Juan Echevarria1,
  4. A Clinton White Jr1,3,
  5. Angelica Terashima1,2,
  6. Frine Samalvides1,
  7. José A Pérez Molina4

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 14 NOV 2012

DOI: 10.1002/14651858.CD007745.pub2


How to Cite

Henriquez-Camacho CAJ, Gotuzzo E, Echevarria J, White Jr AC, Terashima A, Samalvides F, Pérez Molina JA. Ivermectin versus benzimidazoles for treating strongyloides infection (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD007745. DOI: 10.1002/14651858.CD007745.pub2.

Author Information

  1. 1

    Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru

  2. 2

    Hospital Nacional Cayetano Heredia, Lima, Peru

  3. 3

    University of Texas Medical Branch, Department of Internal Medicine, Galveston, USA

  4. 4

    Hospital Ramón y Cajal, Tropical Medicine and Parasitology Unit, Infectious Disease Service, Madrid, Spain

*Cesar AJ Henriquez-Camacho, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Urb. Ingeniería S.M.P., Lima, 31, Peru. chenriquezc@gmail.com.

Publication History

  1. Publication Status: Amended to reflect a change in scope (see 'What's new')
  2. Published Online: 14 NOV 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate ivermectin versus benzimidazoles (including thiabendazole, mebendazole, and albendazole) for treating chronic strongyloides infection.